Carr,Andrew

Institution: University of New South Wales, Australia

Top Collaborators: Cooper DA, Mcallister J, Hakimi O, Beardsworth G, Calmy A, Lavie E, Hirschel B, Macrae K, Bloch M, Tong W, Peacock A, Richardson R, Martin FH, Chaudhury S, Murphy R, Hoy J, Samaras K, Hesse K, , Watson J

Research Interests: Hiv, Human, Treatment, Adults, Risk, Patients, Cell, Cells, Safety, Tissue, Health, Bone, Drugs, Resource, Human Immunodeficiency Virus, Metabolism, Role, Virus, Measures, Patient

Publications

Information and abstracts for author publications
Published Date	Impact	Publication
10/27/2009	9.2	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial.	Abstract
11/12/2009	6.4	The Journal of infectious diseases Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.	Abstract
10/25/2013	6.2	AIDS (London, England) Progression to and spontaneous regression of high-grade anal squamous intraepithelial lesions in HIV-infected and uninfected men.	Abstract
06/30/2010	6.2	AIDS (London, England) Postprandial lipid effects of low-dose ritonavir vs. raltegravir in HIV-uninfected adults.	Abstract
09/09/2010	6.2	AIDS (London, England) Lower arterial stiffness and Framingham score after switching abacavir to tenofovir in men at high cardiovascular risk.	Abstract
08/13/2012	4.7	Current opinion in HIV and AIDS Tolerability of HIV integrase inhibitors.	Abstract
08/24/2010	4.4	Journal of acquired immune deficiency syndromes (1999) Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men.	Abstract
08/22/2011	4.4	Journal of acquired immune deficiency syndromes (1999) CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell counts.	Abstract
03/13/2012	4.4	Journal of acquired immune deficiency syndromes (1999) Adherence to HIV treatment guidelines for comorbid disease assessment and initiation of antiretroviral therapy.	Abstract
09/03/2013	3.7	Regenerative medicine Repairing damaged tendon and muscle: are mesenchymal stem cells and scaffolds the answer?	Abstract
07/01/2011	3.6	Experimental cell research LAMMER kinase Kic1 is involved in pre-mRNA processing.	Abstract
03/12/2013	3.3	Alcoholism, clinical and experimental research The impact of alcohol and energy drink consumption on intoxication and risk-taking behavior.	Abstract
07/19/2012	3.3	The Journal of bone and joint surgery. American volume Orthopaedic trial networks.	Abstract
05/11/2009	3.1	Antiviral therapy A new era of antiretroviral drug toxicity.	Abstract
08/28/2013	3.1	BMC infectious diseases Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report.	Abstract
09/06/2013	3	HIV medicine Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults.	Abstract
07/10/2012	3	HIV medicine Financial stress is associated with reduced treatment adherence in HIV-infected adults in a resource-rich setting.	Abstract
09/06/2013	3	HIV medicine Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: safety, tolerability and adherence.	Abstract
05/10/2010	2.7	Journal of shoulder and elbow surgery / American Shoulder and Elbow Surgeons ... [et al.] Factors associated with satisfaction in patients undergoing elbow surgery: a prospective study.	Abstract
01/09/2013	2.6	Appetite Energy drink ingredients. Contribution of caffeine and taurine to performance outcomes.	Abstract
11/28/2011	2.1	Journal of biomedical materials research. Part B, Applied biomaterials Differential growth on sutures of tendon cells derived from torn human rotator cuff.	Abstract
09/05/2011	2.1	The Surgical clinics of North America Gastric acid and digestive physiology.	Abstract